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FOREWORD 
 The research detailed in this thesis will be submitted to Obesity, the official journal of 
the Obesity Society.  The thesis has been prepared according to the guidelines set forth by the 
Graduate School of Appalachian State University.   
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ABSTRACT 
THE EFFECTS OF 4 WEEKS OF AEROBIC TRAINING ON ARTERIAL STIFFNESS 
AND THE RENIN-ANGIOTENSIN AND ALDOSTERONE SYSTEM ON STAGE ONE 
HYPERTENSIVE, OBESE INDIVIDUALS.  (MAY 2011) 
 
Anne Marie Moody, B.S., High Point University 
Chairperson: Scott R. Collier, PhD 
 
Increases in blood pressure (BP) are directly related to increases in body mass, and 
obesity related hypertension is associated with pronounced activity of the renin-angiotensin-
aldosterone system (RAAS) and increased pulse wave velocity (PWV).  Moderate intensity 
aerobic exercise is known to decrease PWV and serves as a valuable option in the treatment 
of hypertension and obesity.  The purpose of this study was to assess RAAS activity and 
PWV prior to and following 4 weeks of aerobic training program in an unmedicated, pre to 
stage one hypertensive population.  Seven men and three post-menopausal women, (52 ± 3.2 
years old) underwent aerobic training [30 minutes of treadmill exercise, 3 days per week at 
65% of peak oxygen consumption (VO2 peak)].  Body mass index (BMI), VO2 peak, BP, and 
blood markers were taken at baseline, post 4 week control period and post 4 week training 
period.  There were no significant differences in any descriptive characteristics during the 
control period; however, there was a significant decrease in plasma aldosterone (ALDO) 
vi 
(255.4 ± 75 to 215.8 ± 66 pg/ml, p = 0.001) and significant decreases in central PWV, (11.2 
± 0.6 vs.9.8 ± 0.8 m/s; p = 0.04) pre to post exercise training.  These data show that 4 weeks 
of moderate intensity aerobic training decreases central PWV that may be linked with 
decreases in ALDO changes in obese, unmedicated hypertensive individuals.
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INTRODUCTION 
 
The link between obesity and hypertension is well established, as hypertension is six 
times more frequent in obese than in lean individuals (1, 2).  It has been shown that obesity 
related hypertension causes hemodynamic alterations through neurohormonal and structural 
adaptations, as well as metabolic mechanisms (3).  The incidence of obesity and hypertension 
are escalating in the United States, with a doubling of obese individuals since 1980, 
increasing the number of obese hypertensives to almost 41% at present (4).  Obese 
hypertensives have been shown to present with higher systemic blood volumes, resulting in 
greater cardiac output and a concomitant increase in peripheral resistance (3).  A significant 
correlation has been established between the degree of obesity and the rate of pulse wave 
velocity (PWV; 5, 6).  It is well known that an increase in peripheral resistance leads to 
greater PWV, reflected pulse waves, and increased arterial stiffness, resulting in remodeling 
of the heart and vascular walls.  Obese individuals show an increased level of aortic stiffness, 
independent of blood pressure (BP) level, ethnicity and age (6).  The renin-angiotensin-
aldosterone system (RAAS) plays a significant role in BP regulation via changes in plasma 
renin activity (PRA) and aldosterone (ALDO) which may be over expressed in obese 
individuals (7).  Renin cleaved to angiotensin II (ANG II), a powerful vasoconstrictor, has 
been shown to be amplified in both obese animals and humans (7).  Increases in sympathetic 
nerve activity and altered intrarenal physical forces in obesity lead to enhanced renin 
secretion (7).  Attenuation of renin through pharmacological blockade or weight loss have 
been shown to decrease resting BP due to decreases in PRA and ALDO (8).   
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 Moderate intensity, aerobic exercise is prescribed as a cornerstone therapy for the 
prevention and treatment of obesity and hypertension (9, 10).  Previously, our laboratory has 
shown that moderate intensity, aerobic exercise can decrease both resting systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) by 4 millimeter of mercury (mmHg) 
respectively in as little as 4 weeks and confer positive changes in the vasculature and 
autonomic nervous system (11).  Reductions in resting BP as small as 3 mmHg have been 
shown to reduce the incidence of stroke and mortality by 3 and 7 fold respectively (12). 
 There is a paucity of literature investigating the effects of exercise on the RAAS and 
to this author’s knowledge, there are no studies using an unmedicated, pre to stage one 
hypertensive cohort.  Therefore, the purpose of this study was to investigate the effect of 
moderate intensity, aerobic exercise on the RAAS, cardiac autonomic function, and pulse 
wave transit times in an unmedicated, pre to stage one hypertensive population. 
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METHODS & PROCEDURES 
 
Subjects 
 Ten obese, unmedicated, pre to stage one hypertensive individuals (7 males, 3 
females) between 40 and 60 years of age were recruited through local community physicians 
after they had been recently identified with pre (n = 4) or stage one essential hypertension (n 
= 6).  To be included in the study, no subjects had a history of diabetes, coronary heart 
disease, or kidney disease,  all were non-smokers, and none were on any medications, 
including anti-hypertensives or anti-inflammatants as identified by their physicians and in a 
health history questionnaire.  Due to the confounding influence of estrogen on cardiovascular 
measures, only postmenopausal women (history of greater than 12 months of amenorrhea) 
not currently under hormone replacement therapy were recruited.  The study was approved 
by the Institutional Review Board, and all subjects gave written consent.   
 
Experimental Design   
Subjects reported to the clinical research unit at the start of testing, at the end of the 4 
week control period, and at the end of the aerobic training time period.  All blood born 
markers were assessed at 7:00 a.m. hours following a 12 hour fast, followed by their 
cardiovascular, and peak oxygen consumption (VO2 peak) assessment completed within 24 
hours.   
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All subject visits took place at the same time of day to reduce the possibility of 
diurnal influences on physiological parameters.  Pre-testing started with subjects resting 
quietly in the supine position in a dimly lit room for 15 minutes.  Electrocardiogram and 
beat-to-beat blood pressure recordings were then collected for a period of 10 minutes with 
metronome-controlled, paced breathing maintained at 12 breaths per minute.  Following the 
second lab visit, each subject underwent a supervised 4 week aerobic training regimen.  At 
the conclusion of 4 weeks of aerobic training, the subjects were asked to report back to the 
lab within 24 to 48 hours after their last exercise session for post-measurements which 
repeated all of the control and pre-training measurements.   
 
Anthropometric and Body Composition Assessment 
Mass was calculated using a beam scale while stature was measured using a 
stadiometer and recorded to the nearest 0.5 cm. Body mass index (BMI) was calculated as 
weight (kg) divided by height (m) squared.  Body composition assessment was recorded 
following a BodPod whole body plethysmography test (BodPod, Life Measurement Inc., 
Concord, CA).          
 
Maximal Aerobic Capacity  
 VO2 peak was assessed using a customized treadmill protocol that has been used in 
our laboratory.  Briefly, participants began walking at an intensity of 3 miles per hour (mph) 
for a period of 3 minutes.  During the test, intensity was first increased by increasing the 
speed until a comfortable pace was reached, at which point 2.5% grade adjustments every 3 
minutes were necessary to reach volitional fatigue.  Heart rate was measured and recorded 
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once per minute during the protocol using a Polar Heart Rate Monitor (Polar Electro Inc., 
Woodbury, NY).  Ratings of perceived exertion (RPE) were also assessed once per stage 
(13).  Expired gases were analyzed using a Quark b2 breath-by-breath metabolic system 
(Cosmed, Rome, Italy).  Maximal effort was attained when subjects met 3 of the following 4 
criteria: (a) no change in HR with a change in workload, (b) a final RPE score of 17 or 
greater on the Borg scale (scale 6-20), (c) a respiratory exchange ratio (RER) greater than 
1.15, and/or (d) a “plateau” (increase of no more than 150 ml) in oxygen uptake with an 
increase in workload.     
   
Exercise Training 
Values attained from the preliminary exercise testing sessions were used to design the 
aerobic training prescription.  Aerobic training consisted of 30 minutes supervised treadmill 
exercise, 3 days per week at 65% of each individual’s VO2 peak. 
 
Hemodynamic Monitoring   
Each subject underwent a BP measurement in compliance with the World Health 
Organization guidelines prior to the start of each study visit. A manual mercury 
sphygmomanometer with an appropriately sized cuff was used for 3 measurements which 
were averaged for later analyses.  
For the acquisition of BP during cardiac autonomic modulation testing trials, 3 minute 
averages of 10 minute epochs were recorded with the subjects in a supine position, attached 
to a beat-to-beat blood pressure monitoring system via finger plethysmography (Finometer, 
Finapres Medical Systems, The Netherlands).  The Finometer estimates brachial BP using an 
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integrated brachial BP cuff and reconstructs brachial BP waveforms from finger arterial 
waveforms by applying an inverse transfer function, a waveform filter, a level correction, and 
a level calibration(14,15). 
 
Signal acquisition and analysis 
As described in prior studies, beat-to-beat HR was recorded using a modified 3 lead 
configuration (CM5; Biopac Systems, Santa Barbara, CA). The electrocardiogram reading 
was collected online at a sampling rate of 1000 Hz, in real time, and stored on a computer. 
All data were stored off-line and used for analysis at a later time. Off-line signal processing 
was performed at 10 minute epochs. Data were visually inspected for ectopic beats and noise 
and linearly interpolated to provide a continuous data stream. Heart rate peaks were 
automatically detected via an established QRS detection algorithm and used to generate an 
R–R interval time event series (WinCPRS, Turku, Finland).  The continuous data stream was 
re-sampled at 5 Hz and passed through a low-pass impulse response filter with a cutoff 
frequency of 0.5 Hz (16).  Power spectral analysis was performed using a maximum entropy 
method in order to improve temporal resolution (17).  The optimum order of the 
autoregressive model was determined by Akaike’s information criterion.  If this method 
yielded a model order of less than 16, we used 16 to avoid possible shifting of the spectral 
peaks (18).  
The power was calculated by measuring the area under the peak of the power spectra 
density curve. Three peaks were revealed and their corresponding bandwidths defined as 
follows: a high frequency (HF) region (0.15–0.40 Hz) caused by arrhythmic respiratory 
oscillations that is indicative of parasympathetic modulation of the heart; a low frequency 
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(LF) region (0.04–0.15 Hz) related to baroreflex activity and thermoregulatory components 
that is mediated by both the sympathetic and parasympathetic arms of the autonomic nervous 
system; and a very LF component (< 0.04 Hz) resulting from non-harmonic fractal 
oscillations of unknown origin (19).  The very LF component was not used in this study other 
than in calculation of normalized LF and HF heart rate variability.  The power spectra were 
calculated in both absolute and normalized units in order to represent the relative value of 
each power component as a proportion of the total power (TP).  TP was taken as an index of 
overall variability (19) and was used as a global marker of vagal modulation (20). The ratio 
of LF to HF power was used as an indicator of sympathovagal balance (21).  All data 
acquisition and post-acquisition analyses were carried out in accordance with standards put 
forth by the Task Force of the European Society of Cardiology and North American Society 
of Pacing and Electrophysiology (19). 
 
PRA, ANG II, and ALDO 
Blood markers were measured at 7:00 a.m. following a 12 hour fast.  Briefly, blood 
was collected in ice-cold vacutainer tubes containing 5 mM EDTA for 17 beta-estradiol (E2), 
25 mM EDTA for plasma renin activity (PRA), and angiotensin II (ANG II) or 14.3 USP 
units/ml of heparin for aldosterone (ALDO).  PRA is defined as the rate of angiotensin I 
(ANG I) generation from endogenous substrate.  The limit of detection of these assays (in 
pg/ml) is: PRA, 25; ANG II, 2; and ALDO, 25. 
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Treatment of the data 
Data were analyzed by SPSS version 17 (Chicago, IL).  All data were analyzed using 
a 1 x 3 ANOVA with repeated measures and a Bonferroni post-hoc test was performed for 
pairwise comparisons.  If significant interactions were detected, a one-way ANOVA was 
conducted to determine where significant changes in dependent variables lied.  Significance 
was set at an alpha < 0.05 and all data are reported as mean ± SEM unless otherwise stated.  
Normal distribution of the data was assessed with a Shapiro-Wilk test.  Data that were not 
normally distributed were then log transformed (natural log transformation) prior to 
statistical analyses.
 
 
 
RESULTS 
Subjects 
There were no significant changes in any subject characteristics from pre to post training 
(Table 1).  There were no significant changes in any descriptive characteristics following the 
4 week control period (Table 2). 
 
Hemodynamic variables  
SBP and DBP showed a 4 and 5 mm Hg reduction from baseline to post-training, 
respectively (Table 2). 
 
Blood Panel 
No significant changes were observed in any blood variables following the control and 
training periods (Table 3).   
 
RAAS 
No significant changes were observed in PRA (p = 0.081) or ANG II (p = no significant 
differences) from baseline to post-training.  There were significant decreases observed in 
plasma ALDO (p = 0.001) from baseline (255.43 ± 75.6) to post-training (215.79 ± 66.1).  
Results for RAAS variables are displayed in Figures 1, 2, and 3.    
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PWV 
Central PWV (Figure 4) showed a significant decrease (p = 0.04) from baseline (11.2 ± 0.6 
m/s) to post-training (9.8 ± 0.8 m/s) within subjects.  
 
Table 1.  Subject Characteristics (n = 10) 
Variable Baseline Pre-Training Post-Training 
Age (y) 54.1 ± 2.8 - - 
Height (m) 1.62 ± 0.08 - - 
Weight (kg) 73.0 ± 3.0 73.0 ± 5.0 72.5 ± 3.0 
BMI (kg/m²) 33.5 ± 1.4 33.5 ± 1.4 33.5 ± 1.4 
 
Values are mean ± SE for n = 10.  Baseline values taken at initial lab visit.  Pre-training 
values taken at second lab visit, following a 4 week control period.  Post-training values 
taken within 24 hours after the final exercise session.   
 
Y, years; m, meters; kg, kilograms; BMI, body mass index; kg/m², kilograms per meters 
squared 
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Table 2.  Descriptive Characteristics  
Variable Baseline Pre-Training Post-Training 
VO2 (ml/kg/min) 32.4 ± 2.4 - - 
PWV (m/s) 11.2 ± 0.6 11.6 ± 0.4 9.8 ± 0.8* 
PRA (pg/ml) 0.979 ± 0.16 0.845 ± 0.11 0.592 ± 0.10 
ANG II (pg/ml) 934.25 ± 189.90 932.75 ± 177.22 930.84 ± 107.16 
ALDO (pg/ml) 255.43 ± 75.6 252.14 ± 63.1 215.79 ± 66.1* 
SBP (mmHg) 140 140 136* 
DBP (mmHg) 90 89 85* 
 
Values reported as mean ± SE for n = 10. 
*Denotes significance at p < 0.05. 
 
VO2, maximal oxygen intake; PWV, pulse wave velocity; PRA, plasma renin activity; ANG 
II, angiotensin II; ALDO, aldosterone; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; ml/kg/min, milliliters per kilogram per minute; m/s, meters per second; pg/ml, 
picograms per milliliters; mmHg, millimeters of mercury . 
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Table 3.  Blood Panel.   
Variable Control Pre-Training Post-Training 
Sodium 141.4 ± 1.26 141.5 ± 0.85 142.1 ± 1.37 
Potassium 4.0 ± 0.13 4.1 ± 0.12 4.2 ± 0.15 
Chloride 103.7 ± 1.42 104.6. ± 1.65 104.9 ± 1.97  
Carbon Dioxide 26.7 ± 2.36 26.9 ± 1.85 26.2 ± 2.39 
Aniongap 10.4 ± 1.96 10.0 ± 1.05 10.7 ± 1.95 
Serum Calcium 9.1 ± 0.29 9.1± 0.32 9.2 ± 0.36 
Blood Urea Nitrogen  16.2 ± 2.15 16.3 ± 2.63 15.8 ± 2.44 
Creatinine 0.86 ± 0.12 0.88 ± 0.09 0.86 ± 0.12 
Free Calcium 293.2 ± 2.82 294.3 ± 1.64 295.0 ± 3.33 
Glucose 82.4 ± 7.71 83.3 ± 6.57 85.3 ± 10.27 
Hemoglobin 15.1 ± 0.55 16.4 ± 1.2 14.2 ± 1.4 
Hematocrit 43 ± 0.8 44 ± 1.1 42 ± 2.2 
 
Values expressed as mean ± SE in milligrams per deciliter (mg/dl) for n = 10. 
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Figure 1.  Changes in plasma renin activity (PRA) from baseline to post 4 weeks of exercise 
training.  Data are presented as mean ± SE in picograms per milliliter (pg/ml).  Significance 
set at p < 0.05.  No significant differences (NSD) are indicated between any measures.   
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Figure 2.  Changes in angiotensin II (ANG II) from baseline to post 4 weeks of exercise 
training.  Data are presented as mean ± SE in picograms per milliliter (pg/ml).  Significance 
set at p < 0.05.  No significant differences (NSD) are indicated between any measures.   
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Figure 3.  Changes in plasma aldosterone (ALDO) from baseline to post 4 weeks of exercise 
training.  Data are presented as mean ± SE in picograms per milliliter (pg/ml).  Significance 
set at p < 0.05.  No significant differences (NSD) are indicated from baseline to pre-training 
(following 4 week control period).  Significance (*) is indicated from baseline to post 4 week 
training (p = 0.001). 
 
 
 
 
 
 
 
 
 
16 
 
 
PWV
Ba
se
lin
e
Pr
e
Po
st
0
5
10
15
Baseline
Pre
Post
*
m
/s
 
Figure 4.  Changes in pulse wave velocity (PWV) from baseline to post 4 weeks of exercise 
training.  Data are presented as mean ± SE in meters per second (pg/ml).  Significance set at 
p < 0.05.  No significant differences (NSD) are indicated from baseline to pre-training 
(following 4 week control period).  Significance (*) is indicated from baseline to post 4 week 
training (p = 0.04). 
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DISCUSSION 
The major finding of this study was the significant decline in post-training ALDO 
independent of decreases in body composition, which until now has not been demonstrated in 
this population. This finding has been supported in the animal literature, yet human studies 
have shown mixed results.  Aerobic exercise is known to improve vascular health primarily 
through suppression of neurohumoral vasoconstrictors, sympathetic tone, and signaling of 
nitric oxide release (22).  The RAAS is a central mediator on the cardiovascular influence of 
these components.     
 
Exercise and Hypertension 
Aerobic exercise has been shown to reduce BP and markers of arterial stiffness, even 
without changes in aerobic fitness or body composition (23).  Declines in elevated BP with 
aerobic training occur after a mere 1-4 weeks of moderate intensity exercise (11, 24), and this 
data is further supported in the present study.  Literature addressing RAAS reductions in an 
unmedicated hypertensive group following aerobic training is relatively absent.  In a human 
model, 6 months of aerobic training lowered plasma ALDO in pre-hypertensive and 
hypertensive subjects, some previously treated pharmacologically (25).  These results were, 
however, associated with a loss of intra-abdominal fat and without changes in BP.  Kohno 
and colleagues reported that individuals with hypertension and elevated baseline PRA 
showed the greatest decreases in BP after 3 weeks of moderate intensity training (26), and 
other studies have produced similar results (27).
 
PWV 
 It is known that a relationship exists between plasma ALDO concentrations and 
arterial PWV in a hypertensive population, likely a result of localized mineralcorticoid 
receptor activity within the endothelium (28, 29).  It is further known that carotid-femoral 
PWV measurement is most directly linked to assessment of cardiovascular morbidity and 
mortality risks (22, 30).  Park et al. showed significant association with serum ALDO and 
central PWV, but not in peripheral measurements (31), which may indicate ALDO as more 
influential in the central vasculature.  In the Framington Heart Study, Lieb and colleagues 
repeated these findings correlating ALDO-to-renin ratio with multiple vascular measures, to 
include carotid-femoral PWV (32).   
ALDO blockade is a common intervention in the treatment of hypertension and 
arterial stiffness.   Matsui et al. showed reductions in central PWV after 12 weeks of 
hydrochlorothiazide therapy (p = 0.004; 28).  The influence of aerobic exercise on this 
relationship has been scarcely researched, and even less is available in an unmedicated 
group.  As previously stated, obese individuals present with aortic stiffness, which was 
demonstrated in the respective cohort (baseline PWV = 11.2 ± 0.6 m/s).  Central PWV 
measurements revealed an overall reduction (12.5%) in transit time following 4 weeks of 
aerobic training (post PWV = 9.8 ± 0.8 m/s).  Previous studies have indicated factors 
associated with weight loss as mediation for improved vascular smooth muscle tone and 
artery compliance (33, 34).  The present study is the first to match such findings in an obese, 
hypertensive group with associated decreases in ALDO concentration, following aerobic 
exercise training and without weight loss. 
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The Influence of Aerobic Exercise on RAAS 
Independent of body weight factors, the relationship between obesity and 
hypertension is not fully understood, and current research offers only speculation.  Until now, 
the availability of literature with analysis of ALDO concentrations in human hypertensive 
models is scarce and clinical studies concerning RAAS components on autonomic control are 
few.  Sarzani and colleagues, along with similar studies, acknowledge the dysregulation of 
RAAS coupled with an inhibited cardiac function as having a major role in obesity-
complicated hypertension (7, 35).  Our lab has previously shown small improvements in 
PRA and ANG II following a moderate aerobic exercise program, which was repeated in the 
present study.  Not previously shown in an unmedicated hypertensive pool is the resultant 
data for ALDO concentrations, demonstrating an average 40 point dip from baseline to post 4 
week training in participants. 
 
PRA 
It is well known that accumulated adipose tissue relative to obesity contributes to 
over expression of the RAAS and the up regulation of PRA.  Our study revealed decreases in 
PRA, although not significant, across the group following the training period with matched 
drops in arterial pressures.  This finding is likely consistent with the small sample size and 
correlated power.  Martinelli and colleagues recently found no changes in PRA in overweight 
hypertensives, despite reductions in BP and PWV, and they theorized insufficient weight loss 
as the likely rationale (36).  Previous studies produced similar findings, further indicating a 
negative correlation between decreases in BP and PRA (37, 38) . 
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Comparable to the present study, ten weeks of aerobic exercise lowered plasma 
catecholamines, PRA, and arterial BP in an untreated hypertensive group.  SBP changes were 
significantly matched with changes in PRA (p = 0.005), but not with an average 1.3% drop in 
body fat (p = 0.02; 39).  Decrease in PRA among participants was concluded as a primary 
cause for lowered SBP.   
In a paired study, Higashi and colleagues further evaluated training effects in 
untreated hypertension.  PRA and BP were evaluated after a 12 week training program (5 
days per week, 30 minutes at 50% VO2 max).  SBP and DBP changes were reported as 
significant (p < 0.05), while PRA showed insignificant reductions (p > 0.05; 40, 41). 
 
ANG-II 
 Along with PRA, our study reported modest declines in ANG II. It has been 
suspected that adipocyte markers, specifically elevated plasma leptin hormone, contribute to 
angiotensinogen (AGT) levels in an obese population.  Studies have argued the influence of 
genetic factors on plasma AGT and angiotensin converting enzyme (ACE) activity against 
environmental factors (poor diet, sedentary lifestyle).   The linkage of ANG II cleaving, 
obesity, and hypertension remains inconclusive and studies have produced conflicted results.  
Most recently, an association was seen in ACE genotype, and thus ANG-II, with influence on 
hypertension but not obesity factors (42).  This thought is most in line with our findings, as 
body composition remained unchanged.  Sex differences have been established with the 
recent identification of a sex chromosome effect on BP and increases in mean arterial 
pressure following 2 weeks of ANG II infusion in mice (43).  It is known that chronic ANG-
II signaling from large RAAS activity and hypertension compromises endothelial health and 
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can be pharmacologically moderated via ACE inhibitor therapy.  With respect to ANG II, 
exercise as therapy is mostly explained by alterations in nitric oxide availability (44). 
 
ALDO 
The substantial declines seen with ALDO in the present study are considered the most 
significant finding.  ALDO concentrations, along with renin activity and ANG II, have been 
reported higher in obese subjects when compared to a leaner population (45, 46).  The 
influence of ALDO has been suspected as influential in autonomic control as part of the 
biological pathway of RAAS, but has remained relatively uncertain.  Apart from our study, 
ALDO has not been evaluated in an unmedicated hypertensive cohort.  
Previous studies that have found reductions in ALDO following exercise are few and 
have not produced correlations with matched BP decline.  Jones and colleagues confirmed 6 
months of aerobic exercise as necessary to moderately lower plasma ALDO in medicated and 
unmedicated cohorts with no changes in BP (25).  The dramatic changes in ALDO seen 
within 4 weeks in our study, along with improved BP and PWV, are novel to the hormonal 
influence on vagal function.  The effects of exercise intervention on lowering blood pressure 
and PWV have been shown in normotensive and hypertensive groups, independent of RAAS 
activity and primarily linked to weight loss (47, 48).  Based on the present study, we 
speculate ALDO as the mechanism for observed BP and PWV changes.  Pulse pressure 
measures in the assessment of vascular stiffness have been well established in both obese and 
non-obese groups. Wildman et al. found a positive correlation between excess body weight 
and degrees of aortic stiffness (48).  This dysfunction of the vascular system has been 
theorized to predispose obese persons to accelerated aging of the vasculature and chronic 
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hypertensive conditions.  Since changes in body composition did not persuade the present 
study, the BP and PWV measures of our subjects from baseline to post training appear 
dependent of improved ALDO activity as a function of moderate intensity exercise. 
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